+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating the safety and effectiveness of two different treatment approaches for elderly or unfit participants newly diagnosed with large B-cell lymphoma LBCL. The study compares a regimen of 2 cycles of R-mini-CHOP followed by multiple cycles of the experimental drug AZD0486 against the standard 6 cycles of R-mini-CHOP. This Phase III randomized trial aims to determine if the new combination improves outcomes in this patient population. Participants will be assigned to one of three groups one receiving 2 cycles of R-mini-CHOP followed by AZD0486 at the recommended Phase III dose, another receiving the standard 6 cycles of R-mini-CHOP, and a safety run-in group receiving 2 cycles of R-mini-CHOP followed by AZD0486 at a lower dose. Treatments include intravenous and oral chemotherapy drugs in R-mini-CHOP and an investigational bispecific monoclonal antibody AZD0486. Treatment cycles and dosing schedules are followed over several months according to the assigned group. During the study, participants will be closely monitored for treatment-related side effects and tolerability up to one year, with additional efficacy and safety outcomes assessed up to seven years. Researchers will evaluate response rates, duration of response, progression-free and overall survival, and pharmacokinetics of AZD0486. The long-term follow-up includes regular assessments to measure safety, treatment effects, and survival, ensuring comprehensive data collection over several years of participation.

Age: 65Years - 130YearsAll GendersPhase 3
82 locations